Kavita Aggarwal
Chief Tech/Sci/R&D Officer en VERONA PHARMA PLC .
Perfil
Kavita Aggarwal is a professional with a current job as Senior Vice President-Medical Affairs at Verona Pharma Plc since 2023.
Prior to this, she worked as VP-Global Commercial Pipeline Strategy at BioCryst Pharmaceuticals, Inc. and as Vice President-Medical Affairs at Dova Pharmaceuticals, Inc. Dr. Aggarwal completed her undergraduate degree at North Carolina State University and her doctorate at the University of North Carolina at Chapel Hill.
Cargos activos de Kavita Aggarwal
Empresas | Cargo | Inicio |
---|---|---|
VERONA PHARMA PLC | Chief Tech/Sci/R&D Officer | 01/01/2023 |
Antiguos cargos conocidos de Kavita Aggarwal.
Empresas | Cargo | Fin |
---|---|---|
DOVA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de Kavita Aggarwal.
North Carolina State University | Undergraduate Degree |
University of North Carolina at Chapel Hill | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
VERONA PHARMA PLC | Health Technology |
Empresas privadas | 1 |
---|---|
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Kavita Aggarwal